Cargando…
Treatment Options for Colistin Resistant Klebsiella pneumoniae: Present and Future
Multidrug-resistant (MDR) Klebsiella pneumoniae represents an increasing threat to human health, causing difficult-to-treat infections with a high mortality rate. Since colistin is one of the few treatment options for carbapenem-resistant K. pneumoniae infections, colistin resistance represents a ch...
Autores principales: | Petrosillo, Nicola, Taglietti, Fabrizio, Granata, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678465/ https://www.ncbi.nlm.nih.gov/pubmed/31261755 http://dx.doi.org/10.3390/jcm8070934 |
Ejemplares similares
-
Resistance to Colistin in Klebsiella Pneumoniae: A 4.0 Strain?
por: Granata, Guido, et al.
Publicado: (2017) -
Durlobactam in the Treatment of Multidrug-Resistant Acinetobacter baumannii Infections: A Systematic Review
por: Granata, Guido, et al.
Publicado: (2022) -
Clostridioides difficile and Enterococci’s Interplay in the Human Gut: Bacterial Alliance or Competition? A Systematic Literature Review
por: Granata, Guido, et al.
Publicado: (2023) -
Tackling Acinetobacter baumannii
por: Granata, Guido, et al.
Publicado: (2023) -
Antibiotics Use in COVID-19 Patients: A Systematic Literature Review
por: Granata, Guido, et al.
Publicado: (2022)